1992;267:3758-3763 Vukovich M.D., Costill D.L., Fink W.J
Theres also a trend of greater benefit in physical functioning, body pain and general health domains with greater weight loss. Benefits with both drugs SURMOUNT-5 was a phase 3b randomized controlled open-label trial in which adults with obesity or overweight with at least one obesity-related comorbidity and at least one unsuccessful dietary attempt to lose weight were randomly assigned to once-weekly injectable semaglutide or tirzepatide for 72 weeks
Common and Serious Side Effects Some side effects are fairly common, like nausea, vomiting, diarrhea, and stomach discomfort
Pediatr.Neurol
Linking Appetite Timeline to Weight Loss Outcomes Your weight loss efforts should correlate pretty well with your appetiteup to a point
While those with obesity stand to reap considerable health benefits from fat loss, the potential benefits of fat loss among healthy-weight individuals are minimal and are unlikely to offset the sizable health risks associated with reduced lean mass